Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 03 - 21 crawled time : 08:20 save search
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
Published: 2015-02-19 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.72 -0.07% -0.07% 110K
|
Health Technology
| Email alert
Add to watchlist
phase 2 lung cancer positive cancer trial mm-120 biomarkers
Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results
Published: 2015-02-26 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.72 -0.07% -0.07% 110K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
financial results results
Lifshitz Law Firm, P.C. Announces Investigation of STAY, FI, GNMK, NTEC, RMBL, and SLGG
Published: 2021-03-21 (Crawled : 08:20) - prnewswire.com
RMBL 4 | $5.095 1.49% 1.47% 230K
|
Technology Services
| Email alert
Add to watchlist
JOYY to Announce Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
Published: 2021-03-21 (Crawled : 08:20) - globenewswire.com
YY | $33.39 1.18% 1.17% 250K
|
Technology Services
| Email alert
Add to watchlist
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.